Antibody drug conjugates in non-small cell lung cancer: An emerging therapeutic approach

Medicine and Dentistry

• Non Small Cell Lung Cancer 100%
• Antibody-Drug Conjugate 100%
• Targeted Therapy 40%
• Immune Checkpoint Inhibitor 40%
• Breast Cancer 20%
• Tumor Cell 20%
• Clinical Trial 20%
• Cytotoxic Agent 20%
• Cancer Treatment 20%
• Cytotoxic Chemotherapy 20%
• Urothelial Cancer 20%
• Tyrosine-Kinase Inhibitor 20%

Pharmacology, Toxicology and Pharmaceutical Science

• Non Small Cell Lung Cancer 100%
• Antibody Drug Conjugate 100%
• Malignant Neoplasm 40%
• Immune Checkpoint Inhibitor 40%
• Breast Cancer 20%
• Neoplasm 20%
• Clinical Trial 20%
• Chemotherapy 20%
• Cytotoxic Agent 20%
• Cytotoxic Chemotherapy 20%
• Protein Tyrosine Kinase Inhibitor 20%

Keyphrases

• Design Mode 25%